Betaglycan binds inhibin and can mediate functional antagonism of activin signalling

Kathy A. Lewis, Peter C. Gray, Amy L. Blount, Leigh A. MacConell, Ezra Wiater, Louise M. Bilezikjian and Wylie Vale ()
Additional contact information
Kathy A. Lewis: Clayton Foundation Laboratories for Peptide Biology, The Salk Institute for Biological Studies
Peter C. Gray: Clayton Foundation Laboratories for Peptide Biology, The Salk Institute for Biological Studies
Amy L. Blount: Clayton Foundation Laboratories for Peptide Biology, The Salk Institute for Biological Studies
Leigh A. MacConell: Clayton Foundation Laboratories for Peptide Biology, The Salk Institute for Biological Studies
Ezra Wiater: Clayton Foundation Laboratories for Peptide Biology, The Salk Institute for Biological Studies
Louise M. Bilezikjian: Clayton Foundation Laboratories for Peptide Biology, The Salk Institute for Biological Studies
Wylie Vale: Clayton Foundation Laboratories for Peptide Biology, The Salk Institute for Biological Studies

Nature, 2000, vol. 404, issue 6776, 411-414

Abstract: Abstract Activins and inhibins1, structurally related members of the TGF-β superfamily of growth and differentiation factors2, are mutually antagonistic regulators of reproductive and other functions1,3. Activins bind specific type II receptor serine kinases (ActRII or IIB)4,5,6 to promote the recruitment and phosphorylation of the type I receptor serine kinase, ALK4 (refs 7,8,9), which then regulates gene expression by activating Smad proteins2. Inhibins also bind type II activin receptors but do not recruit ALK4, providing a competitive model for the antagonism of activin by inhibin9,10,11. Inhibins fail to antagonize activin in some tissues and cells, however, suggesting that additional components are required for inhibin action9,12,13. Here we show that the type III TGF-β receptor, betaglycan14,15, can function as an inhibin co-receptor with ActRII. Betaglycan binds inhibin with high affinity and enhances binding in cells co-expressing ActRII and betaglycan. Inhibin also forms crosslinked complexes with both recombinant and endogenously expressed betaglycan and ActRII. Finally, betaglycan confers inhibin sensitivity to cell lines that otherwise respond poorly to this hormone. The ability of betaglycan to facilitate inhibin antagonism of activin provides a variation on the emerging roles of proteoglycans as co-receptors modulating ligand–receptor sensitivity, selectivity and function16,17,18,19.

Date: 2000
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/35006129 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:404:y:2000:i:6776:d:10.1038_35006129

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/35006129

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().